ClinicalTrials.gg
RecruitingNCT06428942LPV in CKDUpdated May 29, 2024

Low-potassium Content Vegetables in Chronic Kidney Disease

An interventional study of low-potassium vegetables in the Recommended Target of Daily Vegetables Intake and Risk of Hyperkalemia, sponsored by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation. Recruiting at 2 sites in Taiwan. Open to participants aged 20 Years to 99 Years. Per ClinicalTrials.gov, last updated 2024-05-29.

Sponsored by Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · Not applicable, Interventional, and Other

From the registry’s dates

  • Primary completion was expected by Dec 2024, 1 year 10 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
75
Allocation
Randomized
Ages
20 Years to 99 Years
Sex
All
01

Study summary

Prior observational studies have shown that higher levels of vegetables and fruits consumption are associated with lower risk of all-cause mortality in patients with chronic kidney disease (CKD). However, compared with the normal population, patients with CKD are more likely to consume less vegetables and fruits. Thus, the investigators aim to evaluate whether proving low-potassium content vegetables to this population are able to reach the recommended target of daily vegetables intake and not increase the risk of hyperkalemia.

Read the detailed description

Prior observational studies have shown that higher levels of vegetables and fruits consumption are associated with lower risk of all-cause mortality in patients with chronic kidney disease (CKD). However, compared with the normal population, patients with CKD are more likely to consume less vegetables and fruits. According to the suggestions from 2018 Ministry of Health and Welfare in Taiwan, vegetables intake are at least 3 to 5 servings daily based on the daily energy requirement. In our own data, the average daily vegetables intake was only 2.1 servings among patients with CKD stages 3 to 5 not yet on dialysis. Therefore, the investigators aim to evaluate whether proving low-potassium content vegetables to patients with CKD stages 3 to 5 not yet on dialysis are able to reach the recommended target of daily vegetables intake and not increase the risk of hyperkalemia.

02

Conditions studied

  • the Recommended Target of Daily Vegetables Intake
  • Risk of Hyperkalemia

Keywords

  • chronic kidney disease
  • vegetables
  • hyperkalemia
03

In context

Renal Insufficiency, Chronic

3,090 studies on the registry are indexed under Renal Insufficiency, Chronic; 698 are open to participants now.

This study's planned enrollment of 75 is close to the median of 73 across 2,157 interventional studies indexed under Renal Insufficiency, Chronic.

Browse Renal Insufficiency, Chronic studies →

Lead sponsor

Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation is the lead sponsor of 58 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • CKD stage 3b\~5, not yet on dialysis
  • Age ≥20 years
  • Stable doses of medications for 4 weeks
  • Serum potassium level: ≥3.5 and \< 5.5 mmol/L

Exclusion criteria

Exclusion Criteria:

  • Anticipated to receive dialysis within 3 month
  • Major gastrointestinal diseases (inflammatory bowel disease, celiac disease) or intestinal resection
  • Patients with infection, , heart failure, liver cirrhosis or impaired cognitive or mental disorders
  • Patients who are just hospitalized due to an acute cardiovascular events or infection 3 months prior to the start of study
  • Patients with kidney transplants
  • Patients who receive
  • Pregnant women or patients who are planning to become pregnant
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

Immunosuppression

A weakened immune system. It can come from an illness, such as HIV or some blood cancers, or from medicines that turn the immune system down, for example after an organ transplant or for an autoimmune disease; steroids at higher doses count.

Read whether the line is about a condition or about medicines, and which medicines and doses it means.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
75 participants (estimated)

Study arms

  • Experimental
    Intervention group

    The participants in the intervention group would receive their daily low-potassium vegetables 3 to 5 serving according to their daily suggested requirement and routine CKD dietary education for 8 weeks.

    Other: low-potassium vegetables

  • No intervention
    Control group

    The participants in the control group would receive routine CKD dietary education for 8 weeks.

Interventions

  • Otherlow-potassium vegetables

    low-potassium vegetables 3 to 5 serving according to their daily suggested requirement

06

What researchers measure

Primary outcomes

  1. Percentage of participants who reach the targets of daily vegetable recommended target

    Percentage of participants who reach the targets of daily vegetable recommended

    Time frame: 8 weeks

Secondary outcomes

  1. Gut-derived uremic toxins

    Change in gut-derived uremic toxins ( indoxyl sulfate, p-cresyl sulfate)

    Time frame: 8 weeks

  2. Serum creatinine

    Change in serum creatinine in mg/dL

    Time frame: 8 weeks

  3. Proteinuria

    Change in proteinuria in g/day

    Time frame: 8 weeks

  4. Occurrence of moderate hyperkalemia

    serum \[potassium\] \>=5.5 mmol/L

    Time frame: 8 weeks

  5. Status of constipation

    Using the Chinese constipation questionnaire. The minimum value is 0, and the maximum value is 21, and the higher score represents a worse outcome.

    Time frame: 8 weeks

  6. Gut microbiome

    Change in alpha- and beta-diversities indices

    Time frame: 8 weeks

07

Study locations

2 of 2 sites recruiting
08

References and documents

Publications

  • Wakasugi M, Yokoseki A, Wada M, Momotsu T, Sato K, Kawashima H, Nakamura K, Onodera O, Narita I. Vegetable and Fruit Intake Frequency and Mortality in Patients With and Without Chronic Kidney Disease: A Hospital-Based Cohort Study. J Ren Nutr. 2023 Jul;33(4):566-574. doi: 10.1053/j.jrn.2023.01.011. Epub 2023 Feb 13. PubMed 36791982 ↗
  • Saglimbene VM, Wong G, Ruospo M, Palmer SC, Garcia-Larsen V, Natale P, Teixeira-Pinto A, Campbell KL, Carrero JJ, Stenvinkel P, Gargano L, Murgo AM, Johnson DW, Tonelli M, Gelfman R, Celia E, Ecder T, Bernat AG, Del Castillo D, Timofte D, Torok M, Bednarek-Skublewska A, Dulawa J, Stroumza P, Hoischen S, Hansis M, Fabricius E, Felaco P, Wollheim C, Hegbrant J, Craig JC, Strippoli GFM. Fruit and Vegetable Intake and Mortality in Adults undergoing Maintenance Hemodialysis. Clin J Am Soc Nephrol. 2019 Feb 7;14(2):250-260. doi: 10.2215/CJN.08580718. Epub 2019 Jan 31. PubMed 31738182 ↗
  • Pourafshar S, Sharma B, Kranz S, Mallawaarachchi I, Kurland E, Ma JZ, Scialla JJ. Patterns of Fruit and Vegetable Intake in Adults With and Without Chronic Kidney Disease in the United States. J Ren Nutr. 2023 Jan;33(1):88-96. doi: 10.1053/j.jrn.2022.06.007. Epub 2022 Jul 5. PubMed 35798188 ↗

Individual participant data

Plan to share: No — We do not have IPD sharing plan.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 29, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06428942
Lead sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Responsible party
Szu-Chun Hung (Professor, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation) — Principal investigator
First posted
May 24, 2024
Start date
May 27, 2024 (estimated)
Primary completion
Dec 31, 2024 (estimated)
Completion
Dec 31, 2024 (estimated)
Last update
May 29, 2024

Study contacts

TIng-Yun Lin, MD
Contact
water_h2o_6@hotmail.com
886-266289779 ext. 2350
Szu-Chun Hung, MD
Contact
szuchun.hung@gmail.com
886-266289779 ext. 2350
Szu-Chun Hung, MD
principal investigator · Taichung Tzu Chi Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion